AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PANTERA MINERALS LTD

0.013

-0.001-7.14%

Volume:115.45K

Turnover:1.54K

Market Cap:6.16M

PE:-0.30

High:0.014

Open:0.014

Low:0.013

Close:0.014

Loading ...

Overview Company News Filings

Top Premarket Decliners

MT Newswires Live

S&P 500 Starts March With Weekly Slide Amid Tariff Worries, Weaker-Than-Expected Jobs

MT Newswires Live

US Indexes Pivot to Gains After Powell Speech Shows Wiggle Room in Rate Decisions on Macro Condition

MT Newswires Live

Why Moderna Stock Has Surged 20% This Week Despite Mixed News

Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court

MT Newswires Live

Pfizer Updates DEI Webpage to Focus on Merit

MT Newswires Live

Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds

Pfizer Appoints Patrizia Cavazzoni as Chief Medical Officer

MT Newswires Live

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Focus on Inflation Data

MT Newswires Live

Summit Therapeutics Partners With Pfizer to Test Cancer Drug Combinations

MT Newswires Live

Pfizer Says Talzenna Combination Improves Overall Survival in Prostate Cancer Study

MT Newswires Live

Pfizer Gets US FDA Approval for Adcetris Combination Regimen for Large B-Cell Lymphoma

MT Newswires Live

Pfizer, Astellas Cite 'Durable Benefit' in More Trial Results of Padcev Plus Keytruda in Urothelial Cancer

MT Newswires Live

Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires Live

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.

Top Midday Stories: China Retaliates With Tariffs, Antitrust Probe of Google; Merck Shares Tumble on Downbeat Guidance

MT Newswires Live

Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?

Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Tuesday as China Responds to US Tariffs

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PFE.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE.AU\",,,,,undefined,":{"symbol":"PFE.AU","market":"AU","secType":"STK","nameCN":"PANTERA MINERALS LTD","latestPrice":0.013,"timestamp":1749190320000,"preClose":0.014,"halted":0,"volume":115447,"delay":0,"nameEN":"PANTERA MINERALS LTD","floatShares":307273263,"shares":473783688,"eps":-0.043813,"marketStatus":"Market Closed","change":-0.001,"latestTime":"06-06 16:12:00 AEST","open":0.014,"high":0.014,"low":0.013,"amount":1537,"amplitude":0.071429,"askPrice":0.014,"askSize":245673,"bidPrice":0.013,"bidSize":700362,"shortable":3,"etf":0,"ttmEps":-0.043813,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.014,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":0.2759394614703392,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFE.AU\",,,,,undefined,":{"symbol":"PFE.AU","floatShares":307273263,"roa":"-48.29%","roe":"-79.97%","lyrEps":-0.043813,"volumeRatio":0.2759394614703392,"shares":473783688,"dividePrice":0,"high":0.014,"amplitude":0.071429,"preClose":0.014,"low":0.013,"week52Low":0.013,"pbRate":"0.47","psRate":"-134.13","week52High":0.049,"institutionHeld":0,"latestPrice":0.013,"committee":0.480626,"eps":-0.043813,"divideRate":0,"volume":115447,"delay":0,"ttmEps":-0.043813,"open":0.014,"prevYearClose":0.018,"prevWeekClose":0.014,"prevMonthClose":0.014,"prevQuarterClose":0.017,"fiveDayClose":0.014,"twentyDayClose":0.014,"sixtyDayClose":0.016},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFE.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518066710","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2518066710","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518066710?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:58","pubTimestamp":1741694335,"startTime":"0","endTime":"0","summary":"Zymeworks  shares slumped 46% pre-bell Tuesday, adding to Monday's losses.Arvinas  shares retreated 41% after the company and Pfizer  said their phase 3 trial of vepdegestrant for the treatment of breast cancer failed to reach statistical significance in improvement in progression free survival in the intent-to-treat population.Evolus  shares fell 36% after Monday's 6.6% loss.Stoke Therapeutics  shares decreased 36% following a muted session.Medallion Financial  shares were down 32% after a 2.4% gain in the previous session.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0321505868.SGD","EOLS","SG9999002232.USD","STOK","LU0985481810.HKD","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4007","PFE","IE00B19Z3581.USD","LU1066053197.SGD","PFE.AU","SG9999001176.SGD","BK7095","LU0122379950.USD","BK4533","LU0225284248.USD","LU0289739699.SGD","BK4550","MFIN","ZYME","LU1894683264.USD","ARVN","BK4599","SG9999001176.USD","SG9999013999.USD","LU0306807586.USD","LU0456855351.SGD","IE0002270589.USD","LU0170899867.USD","LU0306806265.USD","LU1023059063.AUD","SGXZ57979304.SGD","LU1066051498.USD","LU1894683348.USD","LU1057294990.SGD","BK4592","BK4568","LU1883839398.USD","BK4139","BK4588","BK4534","BK4585","LU0234572021.USD","IE00BLSP4239.USD","BK4166","IE000M9KFDE8.USD","BK4581","IE00BBT3K403.USD","SG9999003800.SGD"],"gpt_icon":0},{"id":"2517466189","title":"S&P 500 Starts March With Weekly Slide Amid Tariff Worries, Weaker-Than-Expected Jobs","url":"https://stock-news.laohu8.com/highlight/detail?id=2517466189","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517466189?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:42","pubTimestamp":1741383728,"startTime":"0","endTime":"0","summary":"The Standard & Poor's 500 index fell 3.1% this week, pushing the market benchmark into the red for the year amid worries about tariffs and a weaker-than-expected February jobs report.The S&P 500 ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3964cc85167a5c9f1b21209e1177d6ab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002270589.USD","ADBE",".DJI","BK4588","LU1366333091.USD","LU1989764664.SGD","NQmain","BK4535","VOO","LU0861579265.USD","KKR","BBY","MNQmain","DOG","LU1815336760.USD","UDOW","NVIW.SI","TSYW.SI","SPY","SQQQ","PFE.AU","PSQ",".IXIC","QID","SDOW","QLD","BK7095","DJX","BNTX","LU2095319765.USD","LU2458330243.SGD","LU2125154935.USD","DDM","FANG.AU","LU0511384066.AUD","USJW.SI","LU0234572021.USD","USAW.SI","LU0348723411.USD","DXD","BK4170","TQQQ","LU0320765059.SGD","FANG","HPE",".SPX"],"gpt_icon":1},{"id":"2517452551","title":"US Indexes Pivot to Gains After Powell Speech Shows Wiggle Room in Rate Decisions on Macro Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2517452551","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517452551?lang=en_us&edition=fundamental","pubTime":"2025-03-08 03:15","pubTimestamp":1741374907,"startTime":"0","endTime":"0","summary":"US equity indexes rose after midday Friday, clawing back from earlier declines, after Federal Reserve Chair Jerome Powell reiterated policymakers can still afford to wait for more clarity on a host of","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE000M9KFDE8.USD","DJX","IE0002270589.USD","US7Y.BOND","BK4170","UDOW","LU0985481810.HKD","PFE","LU0170899867.USD","LU1883839398.USD","NVIW.SI","PFE.AU","DOG","DXD","QLD","MRNA","US30Y.BOND","MNQmain",".SPX","SDOW","USAW.SI","USJW.SI","LU0321505868.SGD","IE00BLSP4239.USD","BNTX","BK4532","US2Y.BOND","BK4533","US6M.BOND","NQmain",".IXIC","US5Y.BOND",".DJI","QID","SQQQ","DDM","TQQQ","TSYW.SI","US12M.BOND","BK4501","US10Y.BOND","US3Y.BOND","LU0306806265.USD","PSQ","LU1023059063.AUD","LU0234572021.USD","HPE","LU0868494617.USD"],"gpt_icon":1},{"id":"2517621457","title":"Why Moderna Stock Has Surged 20% This Week Despite Mixed News","url":"https://stock-news.laohu8.com/highlight/detail?id=2517621457","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517621457?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:58","pubTimestamp":1741366689,"startTime":"0","endTime":"0","summary":"Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market.","market":"nz","thumbnail":"https://www.investors.com/wp-content/uploads/2021/12/Stock-moderna-12-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2021/12/Stock-moderna-12-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/moderna-stock-executives-buy-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4534","LU0985481810.HKD","LU1829250122.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1894683348.USD","LU0225771236.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU0306807586.USD","LU1066053197.SGD","BK4581","LU1894683264.USD","IE00B19Z3B42.SGD","BK4568","BK4547","LU0058720904.USD","MRNA","BK4007","BK4585","BK4501","IE000M9KFDE8.USD","SG9999001176.SGD","IE00BLSP4452.SGD","BK4599","LU0321505439.SGD","SG9999013999.USD","BNTX","BK4550","BK4533","GSK.UK","BK4551","IE00B19Z3581.USD","LU0868494617.USD","SG9999002224.SGD","SG9999011175.SGD","BK4548","NVAX","GSK","PFE.AU","IE00BLSP4239.USD","LU1057294990.SGD","SG9999001176.USD","LU1066051498.USD","BK4139","BK4592","LU0456855351.SGD","LU0234572021.USD","BK7095"],"gpt_icon":1},{"id":"2517941134","title":"Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941134","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517941134?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:28","pubTimestamp":1741192136,"startTime":"0","endTime":"0","summary":"Pfizer  and its partner BioNTech  have infringed a COVID-19 vaccine patent owned by Moderna , Reuters reported Wednesday, citing a German court ruling.The court reportedly ordered Pfizer and BioNTech to disclose earnings related to the patent's use and pay a compensation to Moderna, according to the report.Pfizer and BioNTech argued they were permitted to use the technology based on Moderna's public statement until the World Health Organization declared in May 2023 that COVID-19 was no longer a global emergency, the media outlet reported.The court did not determine the compensation amount, which will be decided in further legal proceedings and could change if there is an appeal, Reuters said.Pfizer, BioNTech and Moderna did not immediately respond to requests for comment from MT Newswires.Price: 25.87, Change: +0.12, Percent Change: +0.47","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4550","LU0321505868.SGD","LU0321505439.SGD","BK4548","LU0306806265.USD","LU0868494617.USD","MRNA","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4588","LU1066053197.SGD","LU1066051498.USD","SG9999002232.USD","BK4534","BK4581","IE00BBT3K403.USD","LU0170899867.USD","LU1023059063.AUD","BK4535","BK4568","BK4585","IE000M9KFDE8.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1894683348.USD","BNTX","LU0234572021.USD","SG9999003800.SGD","SG9999002224.SGD","SG9999013999.USD","SG9999001176.USD","BK4501","BK4533","LU0058720904.USD","IE00B19Z3B42.SGD","BK7095","LU0289739699.SGD","IE00BLSP4239.USD","LU0225284248.USD","LU0225771236.USD","LU0456855351.SGD","BK4599","LU1883839398.USD","PFE.AU","SG9999001176.SGD","BK4592","LU0985481810.HKD","BK4139","PFE","IE0002270589.USD"],"gpt_icon":1},{"id":"2514328449","title":"Pfizer Updates DEI Webpage to Focus on Merit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514328449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514328449?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:49","pubTimestamp":1740743395,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) revised its diversity, equity, and inclusion webpage Thursday to focus on merit, reflecting broader adjustments by companies in response to the Trump administration's rollback of DEI poli","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4592","IE0002270589.USD","LU0306806265.USD","LU0225771236.USD","BK4223","BK4568","IE00BBT3K403.USD","BK4194","LU0456855351.SGD","BK4599","SG9999002224.SGD","LU1066051498.USD","LU1883839398.USD","LU1894683348.USD","BK4007","BK4581","LU1023059063.AUD","LU1894683264.USD","BK4533","DEI","LU0868494617.USD","LU0122379950.USD","BK4585","LU0234572021.USD","LU0306807586.USD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0321505868.SGD","BK4550","SG9999013999.USD","LU1066053197.SGD","LU0170899867.USD","SG9999003800.SGD","IE00BLSP4452.SGD","SG9999001176.USD","SGXZ57979304.SGD","LU0289739699.SGD","BK4534","BK4588","BK7095","LU0985481810.HKD","LU0225284248.USD","IE00BLSP4239.USD","LU0321505439.SGD","LU1057294990.SGD","LU0058720904.USD","PFE","PFE.AU"],"gpt_icon":1},{"id":"2514233439","title":"Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2514233439","media":"Blockhead","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514233439?lang=en_us&edition=fundamental","pubTime":"2025-02-28 03:30","pubTimestamp":1740684637,"startTime":"0","endTime":"0","summary":"Moderna stock toppled Thursday on reports the Trump administration is considering pulling bird flu vaccine funding.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2020/11/Stock-moderna-02-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2020/11/Stock-moderna-02-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/moderna-stock-rfk-jr-bird-flu-vaccine-funds/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1023059063.AUD","BK4581","GSK","LU1829250122.USD","LU1894683264.USD","BK4534","LU1883839398.USD","LU0306807586.USD","LU1894683348.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4007","LU0225771236.USD","BK4501","LU0058720904.USD","GSK.UK","LU1057294990.SGD","BK7095","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","LU0985481810.HKD","LU1066053197.SGD","SG9999001176.SGD","SG9999002232.USD","LU0868494617.USD","BK4533","BK4592","IE000M9KFDE8.USD","LU0170899867.USD","LU0225284248.USD","MRNA","LU0321505439.SGD","PFE.AU","IE00BLSP4239.USD","LU0122379950.USD","BK4550","IE00B19Z3B42.SGD","SNY","IE00BFXG1179.USD","SG9999013999.USD","IE00BBT3K403.USD","BK4585","IE00BLSP4452.SGD","BK4599","BK4139","LU0456855351.SGD","SG9999003800.SGD","SG9999001176.USD"],"gpt_icon":1},{"id":"2514749407","title":"Pfizer Appoints Patrizia Cavazzoni as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2514749407","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514749407?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:01","pubTimestamp":1740420076,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) said Monday Patrizia Cavazzoni will be rejoining the company as chief medical officer.Cavazzoni was most recently the director of the Center for Drug Evaluation and Research at the US Foo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","LU1883839398.USD","LU0985481810.HKD","IE0002270589.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","BK4534","BK4581","IE00BBT3K403.USD","LU1023059063.AUD","LU1057294990.SGD","LU1894683264.USD","BK4599","SG9999001176.SGD","BK7095","SG9999013999.USD","SGXZ57979304.SGD","BK4550","BK4592","LU0306806265.USD","PFE.AU","LU1066053197.SGD","LU0225771236.USD","IE000M9KFDE8.USD","BK4585","IE00B19Z3581.USD","LU0321505439.SGD","SG9999011175.SGD","BK4588","LU0289739699.SGD","SG9999001176.USD","PFE","LU1066051498.USD","LU0868494617.USD","LU0456855351.SGD","LU0321505868.SGD","LU1894683348.USD","LU0170899867.USD","LU0306807586.USD","BK4533","IE00BLSP4239.USD","LU0122379950.USD","LU0234572021.USD","LU0058720904.USD","LU0225284248.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2513724103","title":"Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724103","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724103?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:14","pubTimestamp":1740406493,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to higher pre-bell Monday, with the iShares Biotechnology ETF  inactive and The Health Care Select Sector SPDR Fund  up 0.3%.Invivyd  shares were down past 28% after the company said the US Food and Drug Administration rejected its request to expand the existing emergency use authorization for Pemgarda to include treatment of mild-to-moderate COVID-19 in immunocompromised adults and adolescents.Summit Therapeutics  stock was over 5% higher after the company said it will collaborate with Pfizer  on a set of clinical trials to evaluate ivonescimab, its investigational drug, in combination with several Pfizer antibody drug conjugates to treat multiple solid tumors.Entrada Therapeutics  shares were up more than 5% after the company said the US Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and cleared the company's plan to start a phase 1b study of the product candidate as a potential treatment for adults with Duchenne muscular dystrop","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683264.USD","BK4592","LU0306806265.USD","LU1023059063.AUD","SG9999002232.USD","XLV","LU0321505868.SGD","LU1057294990.SGD","LU0456855351.SGD","SG9999013999.USD","BK4588","LU0225284248.USD","IE00BBT3K403.USD","BK4581","LU0225771236.USD","BK4550","LU0058720904.USD","BK4585","BK7095","BK4599","SG9999003800.SGD","BK4139","LU0985481810.HKD","IBB","IE0002270589.USD","IE000M9KFDE8.USD","LU0170899867.USD","SMMT","IVVD","LU0306807586.USD","TRDA","SG9999001176.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0321505439.SGD","SG9999011175.SGD","LU2488822045.USD","PFE.AU","SG9999002224.SGD","SGXZ57979304.SGD","LU1883839398.USD","LU0868494617.USD","BK4568","IE00B19Z3B42.SGD","BK4007","LU0234572021.USD","BK4534","LU0122379950.USD"],"gpt_icon":1},{"id":"2513726755","title":"Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Focus on Inflation Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726755","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726755?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:16","pubTimestamp":1740403019,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.5% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.4% in Monday's premarket activity as investors focus on upcomi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FAS","VHT.AU","XSD","VHT",".SPX","BITO","RTH.AU","XLF","XLE","VIS","XLI","XLK","SPY","USO","UNG","EQR","KOS","XLP",".DJI","IGM","ISBC","SOXX","IYK","IVV","EXI","IBB",".IXIC","IYE","PFE.AU","QQQ","EQH","FDN","IYW","AB","PMR","IYJ","EEM","SPY.AU","VDC","XLV","SMMT","IPK","RTX","SLV","IGV","RTH","DPZ","IYH"],"gpt_icon":1},{"id":"2513742080","title":"Summit Therapeutics Partners With Pfizer to Test Cancer Drug Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2513742080","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513742080?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:45","pubTimestamp":1740397524,"startTime":"0","endTime":"0","summary":"Summit Therapeutics Inc (SMMT) said Monday it will collaborate with Pfizer (PFE) on a set of clinical trials to evaluate ivonescimab, its investigational drug, in combination with several Pfizer antib","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1023059063.AUD","LU1066051498.USD","BK4581","SGXZ57979304.SGD","SG9999002224.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","LENZ","BK7095","PFE.AU","BK4007","SMMT","IE00BLSP4452.SGD","BK4533","LU0234572021.USD","LU1883839398.USD","LU0868494617.USD","LU0225284248.USD","IE00B19Z3B42.SGD","BK4534","LU0985481810.HKD","SG9999001176.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU2488822045.USD","SG9999003800.SGD","IE00BLSP4239.USD","BK4550","IE0002270589.USD","SG9999011175.SGD","LU0456855351.SGD","SG9999001176.SGD","LU0306806265.USD","LU0225771236.USD","LU0306807586.USD","LU1066053197.SGD","LU0058720904.USD","SMMF","LU0122379950.USD","BK4592","SG9999002232.USD","BK4211","SG9999013999.USD","BK4568","BK4585","LU1057294990.SGD","LU1894683264.USD","PFE"],"gpt_icon":1},{"id":"2511404522","title":"Pfizer Says Talzenna Combination Improves Overall Survival in Prostate Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2511404522","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511404522?lang=en_us&edition=fundamental","pubTime":"2025-02-14 00:10","pubTimestamp":1739463055,"startTime":"0","endTime":"0","summary":"Pfizer  said Thursday that Talzenna plus Xtandi combination improved overall survival in patients with metastatic castration-resistant prostate cancer, with or without homologous recombination repair gene mutations, during a phase 3 trial.The combination showed \"a statistically significant and clinically meaningful improvement in overall survival,\" compared with placebo plus Xtandi, the company said.The safety profile of the combination was generally consistent with the known safety profile of each medicine, Pfizer said.The data have been shared with global health authorities, including the US Food and Drug Administration, to support potential updates of the approved labels for Talzenna, it added.Price: 25.58, Change: +0.11, Percent Change: +0.41","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","IE00B19Z3B42.SGD","LU0170899867.USD","LU1066053197.SGD","SG9999001176.SGD","SG9999001176.USD","LU0122379950.USD","SG9999002232.USD","LU0225771236.USD","PFE.AU","PFE","BK4550","LU1883839398.USD","SGXZ57979304.SGD","BK4592","IE00BBT3K403.USD","IE000M9KFDE8.USD","BK4588","BK4534","LU1894683348.USD","LU0321505868.SGD","LU0058720904.USD","BK4568","BK4599","BK7095","LU1023059063.AUD","LU0985481810.HKD","LU1057294990.SGD","BK4585","IE0002270589.USD","LU0456855351.SGD","LU0321505439.SGD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","BK4533","LU0306806265.USD","SG9999011175.SGD","SG9999003800.SGD","LU0306807586.USD","LU0289739699.SGD","LU1066051498.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4007","LU0234572021.USD","LU1894683264.USD","IE00B19Z3581.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2511045588","title":"Pfizer Gets US FDA Approval for Adcetris Combination Regimen for Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2511045588","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511045588?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:58","pubTimestamp":1739383082,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) said Wednesday that the US Food and Drug Administration approved its supplemental biologics license application for Adcetris in combination with lenalidomide and a rituximab product for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","BK4588","BK4592","BK4533","IE00B19Z3581.USD","LU1057294990.SGD","SG9999001176.USD","BK4568","SG9999002232.USD","LU0122379950.USD","IE00BLSP4239.USD","LU1066051498.USD","LU0306806265.USD","LU0456855351.SGD","PFE.AU","LU0321505439.SGD","SG9999011175.SGD","IE00BLSP4452.SGD","LU0225771236.USD","LU1066053197.SGD","BK4534","LU0289739699.SGD","BK4007","BK7095","IE00BBT3K403.USD","LU0058720904.USD","LU0170899867.USD","LU0225284248.USD","BK4585","SG9999002224.SGD","LU1883839398.USD","PFE","LU0234572021.USD","LU1023059063.AUD","SG9999003800.SGD","LU1894683348.USD","LU0868494617.USD","LU1894683264.USD","BK4599","BK4581","LU0321505868.SGD","SGXZ57979304.SGD","BK4550","SG9999013999.USD","LU0306807586.USD","IE0002270589.USD","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2510781927","title":"Pfizer, Astellas Cite 'Durable Benefit' in More Trial Results of Padcev Plus Keytruda in Urothelial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2510781927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510781927?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:53","pubTimestamp":1739228009,"startTime":"0","endTime":"0","summary":"Pfizer  and Astellas Pharma said additional follow-up results from a phase 3 clinical trial of Padcev plus Keytruda in first-line treatment of locally advanced or metastatic urothelial cancer showed a sustained overall survival and progression-free survival benefit.The results were consistent with the findings of a primary analysis following an additional 12 months of follow-up, the companies said Monday in a statement.The combination therapy lowered the risk of death by 49%, compared with chemotherapy, while the median overall survival was 33.8 months for the combination versus 15.9 months for chemotherapy.The latest results of the trial \"show a durable benefit,\" Ahsan Arozullah, head of oncology development at Astellas, said in the statement. The findings show \"the potential survival benefit has become even more robust with extended follow up and further solidify the combination as standard of care,\" said Thomas Powles, Barts Cancer Center director in London and the study's primary i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b68b91779c1270fe944d25cf0021e5aa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU0265550946.USD","SG9999002232.USD","LU0985481810.HKD","LU1929549753.HKD","LU0320765646.SGD","LU0266013472.USD","LU0861579265.USD","PFE","LU1066053197.SGD","PFE.AU","LU0122379950.USD","LU1037948541.HKD","BK4533","LU0289739699.SGD","LU2324357040.USD","MRK","IE00BJT1NW94.SGD","LU1066051811.HKD","SG9999001176.USD","SG9999013999.USD","LU0225771236.USD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU2361044949.HKD","LU0170899867.USD","LU1571399168.USD","LU1894683348.USD","LU0211331839.USD","LU1934455194.USD","LU2461242641.AUD","LU1989772840.SGD","IE00BSNM7G36.USD","LU1883839398.USD","BK4588","LU1093756168.USD","SG9999001440.SGD","BK4585","IE00B1BXHZ80.USD","IE0002141913.USD","LU0234572021.USD","LU0965509101.SGD","BK4581","IE00BBT3K403.USD","SG9999003800.SGD","LU1116320901.HKD","SG9999015341.SGD"],"gpt_icon":1},{"id":"2509278030","title":"Arcutis Soared In 2024, Blazing Trails In Dermatology. Why Its CEO Eyes Bigger Gains.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278030","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509278030?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:00","pubTimestamp":1738846850,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics has a lofty goal for 2025 — and it could help Arcutis stock continue a massive run that helped shares quadruple last year.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2025/02/TECH1_watanabe_020725-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/02/TECH1_watanabe_020725-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/arcutis-biotherapeutics-arcutis-stock-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1894683264.USD","REGN","IE00B1BXHZ80.USD","LU0708995401.HKD","BK4599","LU1093756168.USD","ARQT","BK7095","LU0289739699.SGD","SG9999015945.SGD","IE00BJJMRZ35.SGD","SG9999001176.USD","IE00B2B36J28.USD","BK4533","LU1061106388.HKD","LU1868836914.USD","LU0109394709.USD","LU0058720904.USD","LU0640476718.USD","SG9999015952.SGD","SNY","AZN","LLY","SG9999001176.SGD","IE00BFTCPJ56.SGD","IE0004445239.USD","LU0354030438.USD","IE00BBT3K403.USD","LU1035775433.USD","BK4588","LU2360106947.USD","PFE.AU","LU0234572021.USD","LU0306807586.USD","IE000M9KFDE8.USD","LU0882574139.USD","LU2491049909.HKD","BK4581","BK4550","LU2089984988.USD","LU1066051498.USD","LU1712237335.SGD","LU1267930730.SGD","PFE","LU1623119135.USD","LU1280957306.USD","LU0882574055.USD","LU2461242641.AUD","LU2362541273.HKD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2509983794","title":"Sector Update: Health Care Stocks Decline Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2509983794","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509983794?lang=en_us&edition=fundamental","pubTime":"2025-02-05 02:50","pubTimestamp":1738695023,"startTime":"0","endTime":"0","summary":"Health care stocks were softer Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  both down 0.4%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  issued a downbeat full-year outlook, overshadowing stronger-than-expected Q4 results. The shares fell past 10%.Pfizer's  Q4 results topped market expectations amid double-digit revenue growth across key segments, while the pharmaceutical giant reiterated its full-year outlook. Its shares were down 1.7%.Novartis  is on the hunt for next-generation obesity drug candidates, despite its main focus remaining on therapeutic areas where it has an established presence, The Wall Street Journal reported Tuesday, citing an interview with Chief Executive Vasant Narasimhan. Novartis shares were fractionally lower.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0868494617.USD","IE00BLSP4452.SGD","LU2361044865.SGD","NVS","LU0965509010.AUD","LU1093756168.USD","LU1023059063.AUD","LU0320765646.SGD","BK4534","IE00BJT1NW94.SGD","LU1983299246.USD","LU0985320562.USD","PFE.AU","BK4007","SG9999015341.SGD","LU1093756325.SGD","LU1894683348.USD","LU0122379950.USD","SG9999014567.USD","LU1917777945.USD","IE00BSNM7G36.USD","IBB","LU1974910355.USD","SG9999001440.SGD","SG9999014575.USD","XLV","LU0321505439.SGD","BK4532","BK4585","LU2112291526.USD","IE0002141913.USD","BK4568","LU0265550946.USD","MRK","BK4599","LU1699723380.USD","PFE","IE00B19Z3581.USD","LU1934455277.USD","LU1035773651.USD","IE00BBT3K403.USD","LU0265550359.USD","SG9999002232.USD","IE00BFTCPJ56.SGD","BK7095","LU0321505868.SGD","BK4581","LU1066051225.USD","LU0225771236.USD","BK4592"],"gpt_icon":1},{"id":"2509346758","title":"RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509346758","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509346758?lang=en_us&edition=fundamental","pubTime":"2025-02-05 01:50","pubTimestamp":1738691426,"startTime":"0","endTime":"0","summary":"RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines to send his nomination to the full chamber.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2025/02/Stock-RFKjr-01-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/02/Stock-RFKjr-01-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/rfk-jr-biotech-stocks-senate-confirmation/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU0306807586.USD","IE00BLSP4452.SGD","BK4581","BK4139","GSK.UK","BK4599","GSK","SG9999001176.SGD","LU0225771236.USD","LU0225284248.USD","LU0058720904.USD","SG9999011175.SGD","SG9999013999.USD","PFE","LU0170899867.USD","CYBN","LU1883839398.USD","LU0240877869.USD","LU0289739699.SGD","PFE.AU","SGXZ57979304.SGD","LU0321505439.SGD","BK4168","BK4007","BK4534","MRNA","SG9999002232.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4535","BOX","SG9999001176.USD","HHS","BK4592","IE00BLSP4239.USD","LU1894683348.USD","BNTX","BK4532","BK4548","BK4533","BK4023","LU0456855351.SGD","BK4568","SG9999003800.SGD","LU0306806265.USD","BK4550","LU0234572021.USD","LU1894683264.USD","BK4588","LU1829250122.USD"],"gpt_icon":1},{"id":"2509618084","title":"Top Midday Stories: China Retaliates With Tariffs, Antitrust Probe of Google; Merck Shares Tumble on Downbeat Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2509618084","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509618084?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:47","pubTimestamp":1738687650,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were up in late morning trading on Tuesday as investors digest the latest US tariff news.China imposed retaliatory measures on Tuesday after President Donald Trump ann","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BSNM7G36.USD","LU2237443465.HKD","ILMN","LU2271345857.HKD","LU1868837136.USD","LU2491050154.USD","IE000M9KFDE8.USD","PFE.AU","LU1119994496.HKD","SG9999014559.SGD","LU1064131342.USD","LU0742534661.SGD","SG9999014914.USD","LU0985489474.SGD","LU0308772762.SGD","LU0820561909.HKD","LU0094547139.USD","LU1069344957.HKD","LU0266013472.USD","USJW.SI","BK4587","GOOG","LU1066053197.SGD","LU0130103400.USD","PVH","IE00B19Z3B42.SGD","LU0238689110.USD","LU1032955483.USD","LU0642271901.SGD","LU2468319806.SGD","SG9999018857.SGD","LU2361045086.USD","IE00BKPKM429.USD","LU2456880835.USD","IE00BN29S564.USD","LU0353189680.USD","PEP","PFE","LU0310800379.SGD","LU0823421416.USD","PLTR","IE0005OL40V9.USD","LU2106854487.HKD","LU0426412945.USD","MRK","IE00BJJMRZ35.SGD","LU0289739699.SGD","GOOGL","LU0109391861.USD","LU1803068979.SGD"],"gpt_icon":1},{"id":"2508463985","title":"Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463985","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508463985?lang=en_us&edition=fundamental","pubTime":"2025-02-04 23:23","pubTimestamp":1738682635,"startTime":"0","endTime":"0","summary":"Pfizer tock edged lower Tuesday on a \"pretty uneventful quarter\" as revenue from its Covid products helped drive a fourth-quarter beat.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2017/10/stock-Pfizer-01-shutter-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/10/stock-Pfizer-01-shutter-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q4-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4588","LU1894683348.USD","SG9999002232.USD","BK4550","LU0321505439.SGD","LU0985481810.HKD","BK4551","IE00B19Z3B42.SGD","PFE","BNTX","LU0289739699.SGD","SG9999013999.USD","LU0225284248.USD","BK4535","SGXZ57979304.SGD","LU0306807586.USD","IE00BLSP4239.USD","BK4139","IE00BBT3K403.USD","LU0321505868.SGD","BK4007","BK4534","BK4592","LU0122379950.USD","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999002224.SGD","SG9999001176.USD","BK4548","BK7095","LU0234572021.USD","LU1023059063.AUD","LU0306806265.USD","LU0456855351.SGD","SG9999001176.SGD","PFE.AU","LU1066053197.SGD","BK4599","BK4585","LU0225771236.USD","LU0058720904.USD","LU0868494617.USD","LU1883839398.USD","SG9999011175.SGD","BK4533","IE00BLSP4452.SGD","BK4581","LU1066051498.USD","IE0002270589.USD","BK4568"],"gpt_icon":1},{"id":"2508456793","title":"Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Tuesday as China Responds to US Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456793","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456793?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:13","pubTimestamp":1738674826,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up marginally by 0.04% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.2% in Tuesday's premarket activity, as China an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VIS","IBB","SPY.AU","XLE","QQQ","UNG","VDC","VHT","EEM","IPK","XLF","SPY","PLTR","XLI","IYW",".DJI","CNH","MPC","PFE.AU","IVV","IYE","EL","IGV","IYJ","XLP","RTH",".IXIC","EXI","FAS","EQR","XLK","XSD","BITO","IYH","FDN","XLY","RTH.AU","VHT.AU","PFE","XLV","UBS",".SPX","SLV","IGM","IYK","USO","FAZ"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":103,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFE.AU\",market:\"AU\",,,undefined,":[]}}